User profiles for "author:Florian Heitz"

Florian Heitz

Oberarzt der Kliniken Essen-Mitte
Verified email at kem-med.com
Cited by 8636

Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer

SE Bojesen, KA Pooley, SE Johnatty, J Beesley… - Nature …, 2013 - nature.com
TERT-locus SNPs and leukocyte telomere measures are reportedly associated with risks of
multiple cancers. Using the Illumina custom genotyping array iCOGs, we analyzed∼ 480 …

[HTML][HTML] Progression-free survival and safety at 3.5 years of follow-up: results from the randomised phase 3 PRIMA/ENGOT-OV26/GOG-3012 trial of niraparib …

A González-Martín, B Pothuri, I Vergote… - European Journal of …, 2023 - Elsevier
Purpose To report updated long-term efficacy and safety from the double-blind, placebo-
controlled, phase 3 PRIMA/ENGOT-OV26/GOG-3012 study (NCT02655016). Methods …

GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer

PDP Pharoah, YY Tsai, SJ Ramus, CM Phelan… - Nature …, 2013 - nature.com
Genome-wide association studies (GWAS) have identified four susceptibility loci for
epithelial ovarian cancer (EOC), with another two suggestive loci reaching near genome …

Triple-negative and HER2-overexpressing breast cancers exhibit an elevated risk and an earlier occurrence of cerebral metastases

F Heitz, P Harter, HJ Lueck, A Fissler-Eckhoff… - European journal of …, 2009 - Elsevier
PURPOSE: Evaluation of the influence of immunohistochemically defined breast cancer
(BC) subtypes and other risk factors on the development of cerebral metastases (CM) …

Impact of a structured quality management program on surgical outcome in primary advanced ovarian cancer

P Harter, ZM Muallem, C Buhrmann, D Lorenz… - Gynecologic …, 2011 - Elsevier
OBJECTIVE: Surgical outcome in advanced ovarian cancer (AOC) is an important
prognostic factor and the only factor amendable to improvement by optimization. Therefore …

Operability and chemotherapy responsiveness in advanced low-grade serous ovarian cancer. An analysis of the AGO Study Group metadatabase

JP Grabowski, P Harter, F Heitz, E Pujade-Lauraine… - Gynecologic …, 2016 - Elsevier
Objective Since almost two decades standard 1st-line chemotherapy for advanced ovarian
cancer (AOC) has been a platinum/taxane combination. More recently, this general strategy …

Genome-wide meta-analyses of breast, ovarian, and prostate cancer association studies identify multiple new susceptibility loci shared by at least two cancer types

SP Kar, J Beesley, A Amin Al Olama, K Michailidou… - Cancer discovery, 2016 - AACR
Breast, ovarian, and prostate cancers are hormone-related and may have a shared genetic
basis, but this has not been investigated systematically by genome-wide association (GWA) …

[HTML][HTML] Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer

H Shen, BL Fridley, H Song, K Lawrenson… - Nature …, 2013 - nature.com
HNF1B is overexpressed in clear cell epithelial ovarian cancer, and we observed epigenetic
silencing in serous epithelial ovarian cancer, leading us to hypothesize that variation in this …

Pre-operative serum albumin is associated with post-operative complication rate and overall survival in patients with epithelial ovarian cancer undergoing …

B Ataseven, A du Bois, A Reinthaller, A Traut… - Gynecologic …, 2015 - Elsevier
Objective Hypoalbuminemia has been reported as a risk factor for post-operative
complications and unfavorable survival in cancer patients. We aimed to evaluate the …

[HTML][HTML] Prevalence of deleterious germline variants in risk genes including BRCA1/2 in consecutive ovarian cancer patients (AGO-TR-1)

P Harter, J Hauke, F Heitz, A Reuss, S Kommoss… - PloS one, 2017 - journals.plos.org
Background Identification of families at risk for ovarian cancer offers the opportunity to
consider prophylactic surgery thus reducing ovarian cancer mortality. So far, identification of …